Literature DB >> 6822833

Presynaptic cholinergic dysfunction in patients with dementia.

N R Sims, D M Bowen, S J Allen, C C Smith, D Neary, D J Thomas, A N Davison.   

Abstract

Indices of presynaptic cholinergic nerve endings were assayed in neocortical biopsy samples from patients with presenile dementia. For those patients in whom Alzheimer's disease was histologically confirmed, [14C]acetylcholine synthesis, choline acetyltransferase activity and choline uptake were all found to be markedly reduced (at least 40%) below mean control values. The changes occurred in samples from both the frontal and temporal lobes and for [14C]acetylcholine synthesis the decrease was similar under conditions of high and low neuronal activity (as assessed by incubations in 31 mM and 5 mM K+ respectively). Samples from other demented patients, in whom the histological features of Alzheimer's disease were not detected, produced values for all three biochemical parameters which were similar to controls. For the total group of patients with presenile dementia there were correlations between values for the three markers of presynaptic cholinergic nerve endings suggestive of a loss of functional activity at these sites in Alzheimer's disease.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6822833     DOI: 10.1111/j.1471-4159.1983.tb11311.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  69 in total

1.  beta -Amyloid peptide blocks the response of alpha 7-containing nicotinic receptors on hippocampal neurons.

Authors:  Q Liu ; H Kawai; D K Berg
Journal:  Proc Natl Acad Sci U S A       Date:  2001-03-27       Impact factor: 11.205

2.  Agrin in Alzheimer's disease: altered solubility and abnormal distribution within microvasculature and brain parenchyma.

Authors:  J E Donahue; T M Berzin; M S Rafii; D J Glass; G D Yancopoulos; J R Fallon; E G Stopa
Journal:  Proc Natl Acad Sci U S A       Date:  1999-05-25       Impact factor: 11.205

3.  Cholinergic drugs reverse AF64A-induced impairment of passive avoidance learning in rats.

Authors:  N Yamazaki; K Kato; E Kurihara; A Nagaoka
Journal:  Psychopharmacology (Berl)       Date:  1991       Impact factor: 4.530

4.  Glucose metabolism as the site of the primary abnormality in early-onset dementia of Alzheimer type?

Authors:  S Hoyer; K Oesterreich; O Wagner
Journal:  J Neurol       Date:  1988-01       Impact factor: 4.849

5.  A double-blind, placebo controlled trial of high-dose lecithin in Alzheimer's disease.

Authors:  A Little; R Levy; P Chuaqui-Kidd; D Hand
Journal:  J Neurol Neurosurg Psychiatry       Date:  1985-08       Impact factor: 10.154

Review 6.  Estrogen therapy and cognition: a review of the cholinergic hypothesis.

Authors:  Robert B Gibbs
Journal:  Endocr Rev       Date:  2009-12-17       Impact factor: 19.871

7.  Trans-synaptic stimulation of cortical acetylcholine release after partial 192 IgG-saporin-induced loss of cortical cholinergic afferents.

Authors:  J Fadel; H Moore; M Sarter; J P Bruno
Journal:  J Neurosci       Date:  1996-10-15       Impact factor: 6.167

8.  The whole-cell calcium current in acutely dissociated magnocellular cholinergic basal forebrain neurones of the rat.

Authors:  T G Allen; J A Sim; D A Brown
Journal:  J Physiol       Date:  1993-01       Impact factor: 5.182

9.  Ethylcholine mustard aziridinium ion lesions of the rat cortex result in retrograde degeneration of basal forebrain cholinergic neurons: implications for animal models of neurodegenerative disease.

Authors:  P H Stephens; P Tagari; A C Cuello
Journal:  Neurochem Res       Date:  1987-07       Impact factor: 3.996

10.  Synapsin I (protein I) in different brain regions in senile dementia of Alzheimer type and in multi-infarct dementia.

Authors:  E Perdahl; R Adolfsson; I Alafuzoff; K A Albert; E J Nestler; P Greengard; B Winblad
Journal:  J Neural Transm       Date:  1984       Impact factor: 3.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.